Imatinib mesylate-induced interstitial lung disease in a patient with prior history of Mycobacterium tuberculosis infection
Na-Ri Lee, Ji Won Jang, Hee Sun Kim, Ho-Young Yhim
Korean J Intern Med. 2015;30(4):550-553.   Published online 2015 Jun 29     DOI: https://doi.org/10.3904/kjim.2015.30.4.550
Citations to this article as recorded by Crossref logo
Imatinib-induced irreversible interstitial lung disease
Ping Zhang, Jingfeng Huang, Fangfang Jin, Jiaohai Pan, Guifang Ouyang
Medicine.2019; 98(8): e14402.     CrossRef
Update on the management of chronic myeloid leukemia: current best practice and future directions
Aisling Nee, Jeffrey H. Lipton
Expert Opinion on Orphan Drugs.2019; 7(4): 157.     CrossRef
Association between infection and severe drug adverse reactions: an analysis using data from the Japanese Adverse Drug Event Report database
Takuya Imatoh, Kimie Sai, Chisato Fukazawa, Yasushi Hinomura, Ryosuke Nakamura, Yoshimi Okamoto-Uchida, Katsunori Segawa, Yoshiro Saito
European Journal of Clinical Pharmacology.2017; 73(12): 1643.     CrossRef
Imatinib
Reactions Weekly.2015; 1564(1): 104.     CrossRef